Focused Alpha’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$710K Buy
3,044
+50
+2% +$11.6K 0.18% 108
2026
Q2
$635K Buy
2,994
+29
+1% +$5.69K 0.16% 123
2026
Q1
$581K Buy
2,965
+213
+8% +$41.4K 0.18% 118
2025
Q4
$478K Buy
+2,752
New +$501K 0.14% 152

Other funds holding DGX

Focused Alpha's DGX Position: Q3 2026 in Review

Focused Alpha increased its Quest Diagnostics (DGX) stake by 1.7% in Q3 2026, buying an estimated $11.6K and bringing the position to 3,044 shares worth $710K. The position accounts for 0.18% of the portfolio, ranked #108.

Focused Alpha first reported a position in DGX in Q4 2025 and has held it in 4 quarters since. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Focused Alpha held 3,044 shares of Quest Diagnostics worth $710K as of Q3 2026.
  • Focused Alpha bought 50 Quest Diagnostics shares in Q3 2026, an estimated $11.6K.
  • Quest Diagnostics made up 0.18% of Focused Alpha's portfolio in Q3 2026, its #108 holding.
  • Focused Alpha first reported a position in Quest Diagnostics in Q4 2025 and has held it in 4 quarters since.
  • 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.